Prostate-specific Antigen to Predict Early Success of Focal Therapy: Focusing on Appropriate Endpoints
Eur Urol
.
2020 Aug;78(2):161-162.
doi: 10.1016/j.eururo.2020.05.031.
Epub 2020 Jun 25.
Authors
Parth K Modi
1
,
Scott E Eggener
2
Affiliations
1
Division of Urologic Oncology, Department of Urology, Michigan Medicine, Ann Arbor, MI, USA.
2
Section of Urology, Department of Surgery, University of Chicago Medicine, Chicago, IL, USA. Electronic address: seggener@uchicago.edu.
PMID:
32593531
DOI:
10.1016/j.eururo.2020.05.031
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Male
Prostate-Specific Antigen*
Prostatic Neoplasms*
Substances
Prostate-Specific Antigen